Information about Resilient Pharmaceuticals Europe
My details
*
*
*

Resilient Pharmaceuticals Europe (SRL)

Company information

Status
Active

KVK number

KvK 70942188

VAT Number

NL 858519525 B01
Established
19-02-2018
Last balance sheet year
2023
Company size
Micro 0 FTE
RSIN number
858519525
Principal activity
Natuurwetenschappelijk onderzoek en experimentele ontwikkeling
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Resilient Pharmaceuticals Europe

2023 2021 2020 2019
Equity -512.056 -12 % -457.040 -34 % -342.056 -73 % -197.789
Employees 0 0 0 0

Frequently asked questions

What is the KVK number of Resilient Pharmaceuticals Europe?
The KVK number of Resilient Pharmaceuticals Europe is KvK 70942188
What is the VAT number of Resilient Pharmaceuticals Europe?
The VAT number of Resilient Pharmaceuticals Europe is NL 858519525 B01.
Wat is the PEPPOL ID of Resilient Pharmaceuticals Europe?
There is no information available about the PEPPOL ID of Resilient Pharmaceuticals Europe or the company is not yet registered on the PEPPOL network.
When was Resilient Pharmaceuticals Europe founded?
Resilient Pharmaceuticals Europe was founded on 19-02-2018.
What is the address of Resilient Pharmaceuticals Europe?
The current registered office of Resilient Pharmaceuticals Europe is located at Tine van Dethstraat 83, 2331 CD Leiden.
When was the last time Resilient Pharmaceuticals Europe filed their annual financial statements?
The most recent financial statements of Resilient Pharmaceuticals Europe were filed on 31-12-2023.
How many employees does Resilient Pharmaceuticals Europe have?
There are currently no employees working at Resilient Pharmaceuticals Europe or no workforce information is available.
What is the annual turnover of Resilient Pharmaceuticals Europe?
There is no turnover available for Resilient Pharmaceuticals Europe.